Morningside Group

Venture Capital

We invest in a wide range of opportunities.

Hong Kong, Hong Kong · 95+ investments · 57 portfolio companies

Seed

Early Stage

Growth

Biotech

Healthcare

Life Sciences

SaaS

Medtech

digital health

life sciences

novel science

Digital Health

E-Commerce

Headquarters: Hong Kong, Hong Kong
Founded: 1987
Website: morningside.com
AUM: $2.2B

Portfolio Companies: 57
Total Investments: 95
Last Investment: Mar 2026
Geographic Focus: Asia, North America, United States, China, Global

Investment Thesis

We invest in a wide range of opportunities.

Morningside Group is a Venture Capital firm based in Hong Kong, Hong Kong. It has made 95 investments in Biotech and Healthcare, including GreenLight Bio, Adjuvance Technologies and Vigeo.

Portfolio57

Investment History

Sign up to view investment history

Create a free account — 10 credits a month to unlock deal history, amounts, and round details.